Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
about
Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosisInhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma CellsCabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor.Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes.Endogenous prolactin generated during peripheral inflammation contributes to thermal hyperalgesia.Effect of dopaminergic drug treatment on surgical findings in prolactinomas.GDNF--a potential target to treat addiction.Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies.Ergot alkaloids: structure diversity, biosynthetic gene clusters and functional proof of biosynthetic genes.Prolactinoma and hyperprolactinaemia: a transcultural comparative study between Germany as a western, liberal, industrialised country and Syria as an oriental society with a strong Islamic tradition.Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis.Prolactinoma presenting as unilateral galactorrhea in a man exposed to radioactivity from the Chernobyl accident: radiation-induced pituitary tumor?The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis
P2860
Q27024533-01022804-66F2-4712-80E0-9CE693F8B4B0Q28566101-5FD6529B-411D-442E-A4B7-347CB07A710DQ33584061-6FEEA755-9FBC-4AED-80B0-9016CE30ACFAQ33954437-18AF2B41-4A19-43AE-87F9-6F3F6CE34D96Q34620547-28459722-4416-46A3-A925-31AD856B0E5EQ35201419-40E2EC46-7C24-4C5E-9C78-BD13ED2DF82BQ36182003-FC5CD045-4E9D-48E5-8E2C-B4C25D3E1D4FQ36928841-621057FF-3CA5-40C9-998F-F861DA416A66Q37402278-AC9C7BE7-CBDB-4708-9B48-A0952DCE61F1Q37824132-3906BE12-122E-45FC-BA99-0D4739382D16Q43054906-735E7738-5BBC-47E7-B955-373171F4D8F7Q47771504-B23D4295-997A-4688-90DC-A7EA32D12CC7Q48666684-32F2F1ED-08F7-43FD-B9BA-974222546C3EQ58556107-74B9D31B-E1F7-46D7-8274-4F039BDAB778
P2860
Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@ast
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@en
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@nl
type
label
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@ast
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@en
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@nl
prefLabel
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@ast
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@en
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@nl
P2093
P2860
P356
P1476
Drug insight: Cabergoline and ...... rolactinemia in men and women.
@en
P2093
Alberto Mentone
Antonella Di Sarno
Ermelinda Guerra
Monica De Leo
P2860
P304
P356
10.1038/NCPENDMET0160
P577
2006-04-01T00:00:00Z